Fidson hails BoI, EIB  roles  in expanding pharmaceutical manufacturing

Fidson Healthcare Plc, one of Nigeria's most prominent pharmaceutical companies, has publicly acknowledged the significant role played by the Bank of Industry (BoI) and the European Investment Bank (EIB) in supporting the expansion of pharmaceutical manufacturing within the country. This recognition came following a recent visit by representatives from both institutions to Fidson's manufacturing plant located in Sango-Ota, Ogun State. The visit marked a pivotal moment in the ongoing collaboration between these entities, which aims to bolster local production of essential healthcare products such as medicines, vaccines, and diagnostic tools. The initiative stems from a €50 million healthcare financing partnership established between the EIB Global and the BoI. This financial arrangement seeks to enhance the capacity of Nigerian firms to produce critical medical supplies domestically, thereby reducing reliance on imports and strengthening national healthcare infrastructure. During their visit, officials from the EIB and BoI were given a detailed tour of Fidson's facilities, where they observed firsthand the impact of the funding on the company's operations and growth trajectory. Representing the BoI, Mr. Rotimi Akinde, Executive Director of Corporate Finance and Sustainability, emphasized the long-standing relationship between the bank and Fidson. He noted that since 2010, the BoI has consistently offered concessionary financing to facilitate Fidson's expansion efforts. According to Akinde, this strategic financial support has contributed significantly to the company's remarkable growth over the past decade. Mr. Ambroise Fayolle, Vice-President of the European Investment Bank, expressed his satisfaction upon visiting Fidson as one of the initial recipients of the new credit line under the EIB-BoI partnership. He highlighted that just a few months after the signing of the €50 million agreement, the bank had already begun witnessing tangible outcomes from its investment in Nigerian healthcare manufacturing. His remarks underscored the importance of such collaborations in fostering sustainable economic development and improving public health outcomes. From Fidson's perspective, the benefits of this partnership have been profound. Mr. Biola Adebayo, Managing Director of Fidson Healthcare Plc, stated that the support from the BoI has been crucial in enabling the company's transformation. Since 2010, when the firm employed around 250 individuals, its workforce has grown substantially to approximately 1,800 employees. Additionally, the financial backing has allowed Fidson to invest in modern, eco-friendly manufacturing technologies, aligning with global standards for environmental sustainability. This collaborative effort represents a broader trend in international development finance, where partnerships between multilateral banks and local institutions aim to stimulate industrial growth and self-sufficiency in developing economies. By focusing on sectors vital to public health, such initiatives not only contribute to economic resilience but also address pressing social challenges related to access to quality healthcare services. As Fidson continues to expand its operations, it serves as a model for how targeted financial interventions can catalyze meaningful change in the pharmaceutical industry across Africa.